Modern approaches to the treatment of patients with functional constipation
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 4
Abstract
Objective — to study the efficacy and tolerability of the Lactofor® complex (Ananta Medicare) in outpatients with the verified diagnosis of functional constipation (FC) according to Rome criteria IV. Materials and methods. The study involved 30 outpatients with FC aged 33- 59 years (mean age 47.6 ± 5.9 years), with an average disease duration of 14.9 ± 4.8 years, who were treated with the Lactofor® complex during 28 days: the first 5 days — 2 sachets per day, followed by 1 — 2 sachets per day. The treatment effectiveness was assessed by the dynamics of defecation frequency, the feces according the Bristol scale, the assessment of pain syndrome and flatulence on the visual analog scale, the hydrogen breath test (HBT) with lactulose. Patients’ status and quality of life were assessed with the use of specialized patient questionnaires (PAC-SYM — Patient Assessment of Constipation Symptoms and PAC-QoL — Patient Assessment of Quality of Life questionnaire). Results. The administration of Lactofor® complex to patients with FC promoted the increase ofbowel movements’ frequency (after 28 days of observation, 100 % of patients reported daily bowel movement, lack of tension and incomplete emptying) and normalization of stool character, which was confirmed by an increase in stool scores according to the Bristol scale (2.07 ± 0.4 vs 3.42 ± 0.25; p < 0.05). The effects of Lactofor® complex on the reduction of FC symptomshas been established, in particular, a decrease in the intensity and severity of flatulence in 1.9 times (p < 0.01), as well as painful abdominal syndrome in 2.1 times (p < 0.01). There was also a clear positive trend in PAC-SYM and quality of life (PAC-QoL) indicators. Reduction of HBT at all intervals of the test confirmed the positive effect of the Lactofor® complex on reducing the severity of the bacterial overgrowth syndrome. Conclusions. The administrationof Lactofor® complex to patients with FC promoted the increase of bowel movements’ frequency, normalization of stool character, it resulted in the reduction ofintensity and severity of flatulence, painful abdominal syndrome, as well as improvement of the quality of life.
Authors and Affiliations
I. M. Skrypnyk, O. F. Gopko, I. G. Kryvoruchko
Keywords
Related Articles
- EP ID EP670162
- DOI 10.30978/MG-2019-4-85
- Views 135
- Downloads 0
Clinical case of compensatory nodular hyperplasia
Despite the fact the benign liver neoplasms are relatively rare diseases, a clinician should be aware of such typical benign liver damage as focal nodular hyperplasia (FNH). The article presents a case report of a 36-yea...
The relationship between the body mass index and the Firmicutes/Bacteroidetes ratio in the intestinal microbioume of the adult population of Ukraine
Objective — to investigate the difference in the composition of the main intestinal microbiota types in the adult population of Ukraine and their relationship with the body mass index (BMI). Materials and methods. Invest...
Ratio of the main phylotypes of gut microbiota in patients with non-alcoholic fatty liver disease and obesity
Objective — to study composition of the main phylotypes of the gut microbiota Bacteroidetes, Firmicutes and Actinobacteria and their ratio Firmicutes/Bacteroidetes in patients with non-alcoholic fatty liver disease (NAFL...
Priorities of the diagnostic search for osteopenic conditions in patients with chronic pancreatitis and hypertensive disease
Objective — to study of the relationship between lactase gene polymorphism (LCT C-13910T) and the determination of the state of biochemical markers of bone metabolism (total and ionized serum calcium, osteocalcin) in the...
The dynamics of results of the esophageal 24-hour multichannel intraluminal impedance-pH monitoring in patients with stable angina and gastroesophageal reflux disease against the background of the basic treatment correction
Due to the mutual aggravating effects in the comorbidity of the stable angina of effort (SAE) and gastroesophageal reflux disease (GERD), the necessity arises for the correction of basic therapy of each of these patholog...